Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    



 

Abby Trotter

Partner | Hall Strategies

Executive Director | Life Science Tennessee & BioTN

As a journalism major at the University of Tennessee Knoxville, Abby Trotter wasn't planning a career in healthcare. Yet, her skill set perfectly aligned with the needs of a burgeoning life sciences industry in a region better known for healthcare services.

"I came into healthcare from a public affairs and economic development perspective," Trotter explained. "When I first moved to Nashville in 1995, I was very involved in both economic development and healthcare initiatives while working at a previous public affairs firm. It was there that I was first exposed to Life Science Tennessee, then called the Tennessee Biotechnology Association."

Launched in 1999, the organization stemmed from groundwork by the Tennessee Department of Economic Development to capitalize on the growth of life sciences in a state rich with resources. "Tennessee has some of the nation's best research institutions - Vanderbilt, St. Jude, UT and Oak Ridge National Laboratory," enumerated Trotter. "Coupled with our specialties in healthcare delivery, we had ... and still have ... a real opportunity to develop a new economic driver for the state."

In 2004, Trotter helped found Hall Strategies, an independent public and government relations firm working with local and national clients on a range of services including government relations and strategic communications. She continued to intersect with Life Science Tennessee through her work at Hall Strategies before being named executive director in 2012.

"Life Science Tennessee is part of a national organization called the Council of State Biotechnology Associations (CSBA) managed through BIO," Trotter explained of the statewide non-profit. With more than 100 company members, the organization's mission is to advance and grow the industry sector through advocacy, partnership and alignment with workforce and economic development activities.

Although she isn't a researcher, Trotter's skills have propelled the organization forward. Seeds planted over the last decade are now bearing fruit. In the last few months, Revance Therapeutics moved its headquarters from Silicon Valley to Nashville, and August Biosciences announced a major expansion. In April, Nashville was named one of the country's 10 fastest-growing biotech hubs for job opportunities.

"Investors are really beginning to see opportunity," said Trotter. She added the Tennessee Legislature more than doubled the funding amount allocated to match Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. "It's an extremely exciting time, and there's more support than ever before."

She is also hopeful the industry will build off the success and collaboration that brought COVID vaccines to the public in record time. "That was only possible because of the partnership that was created between industry, government and providers," Trotter pointed out. "I'd like to see us address other healthcare needs with similar resolve."

She said the nation's opioid epidemic, which was exacerbated by the pandemic, is a prime area where biotech could offer new options. "One very promising treatment is a non-opioid-based pain medicine, Caldolor, which was developed at Vanderbilt and is on the market from local company Cumberland Pharmaceuticals," Trotter said. "We need to look at how science and innovation can continue to solve our most complex public health problems," she added.

Most recently, Trotter took on the executive director position for BioTN. "It's a non-profit focused on creating a pipeline of talent for the life science industry, beginning with STEM programing for secondary education all the way to workforce development programs for scientists and entrepreneurs," she explained.

"My job pulls me in a lot of directions. I'm grateful for that - and I'm mostly responsible for it, as well, if I'm being honest," she admitted with a laugh. "I thrive in this atmosphere, but it can be challenging."

Add, wife and mom to Trotter's roster of roles. "I am married to a high school history teacher, Doug Trotter, who leads an advanced program at Overton High School. I'm a passionate supporter of public education, and both our daughters went to Overton," she noted. Sadie, 18, just graduated and is headed to Purdue to become a commercial airline pilot. Celia, 17, is a rising senior, so the family looks forward to another busy year of college planning.

"The outdoors is my de-stressor," she noted. "I love to be outside - in my garden, on a run in the neighborhood, a hike, or on the lake."

With momentum gathering, Trotter can use a little tranquility before diving back into busy days sharing the state's successful life science story and growing the sector.

 
Share:

Related Articles:


Recent Articles

Doctors Seeing Increase in Young Females with Tics, Verbal Outbursts Similar to Tourette syndrome

An international phenomenon of involuntary movements and vocalizations in adolescent girls, similar to the tics seen in Tourette syndrome, is now believed to be a functional movement disorder.

Read More

KraftCPAs healthcare cybersecurity webinar October 28

Read More

Acadia CEO to Retire

The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO.

Read More

NEW FINDINGS FROM PRESS GANEY REVEAL MILLENNIAL NURSES ARE MOST LIKELY TO QUIT, AND NEARLY 30% OF NURSES ARE AT RISK OF LEAVING THEIR ORGANIZATION

Flight Risk Analysis of 100,000 U.S.-based healthcare workers underscores the importance of addressing the nurse staffing crisis

Read More

Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegene

New developments in the field of blood biomarkers for brain diseases including traumatic brain injury (TBI), and neurodegenerative diseases such as Alzheimer's, were unveiled during three lectures at the 25th Biennial World Congress of Neurology, October 3-7, 2021, and available virtually through the WCN 2021 portal.

Read More

Ataga Leading $3 Million AI Study For Predicting Kidney Function Decline in Sickle Cell Patients

Kenneth Ataga, MD, Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC), was recently awarded $3.2 million from the National Heart, Lung and Blood Institute for a project that enlists artificial intelligence in the fight against sickle cell disease.

Read More

Research Team Awarded $3 Million to Study Weight Loss, Bone Frailty Link in Diabetics

Two researchers in the Department of Preventive Medicine at the University of Tennessee Health Science Center have received a $3 million award from the National Institute on Aging to study why bones become more frail and prone to fracture in diabetics who achieve long-term weight loss.

Read More

AMA Publishes New Study Monitoring Competition in U.S. Health Insurance Markets

Twentieth edition of AMA study shows continued lack of competition

Read More

Grant Creates Center for Maternal, Pediatric Precision Therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).

Read More

Change in Respiratory Care Strategies for Preterm Infants Improves Health Outcomes

A decade's worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: